Our open access, online journal, ESMO Open is now listed in Pubmed Central, only 10-months after launch. Learn more about the journal!
There are many good reasons to become an ESMO member. Find out why you should join Europe's leading medical oncology society
ESMO’s flagship scientific journal, Annals of Oncology, publishes editorials, reviews, original articles and letters related to oncology
In this video interview, Giannis Mountzios and Stefan Bielack, Co-Chairs of the ESMO/SIOPE Cancer in Adolescents and Young Adults (AYA) Working Group speak about collaboration and combining expertise for a group of patients that represents a unique constellation, patients who are neither adults nor children, and who deserve the best from both societies.
18 Aug 2017
With the addition of the new indication, a tablet formulation of olaparib is introduced
18 Aug 2017
First FDA-approved treatment specifically for patients with therapy-related AML or AML with myelodysplasia-related changes
17 Aug 2017
The survivorship phase in cancer care poses many challenges. With just five minutes of your time, let us understand how you are addressing these important issues.
17 Aug 2017
Prospective analysis of plasma EBV DNA to screen for nasopharyngeal cancer
16 Aug 2017
Promoting digital innovation in health and care
15 Aug 2017
It is indicated in AML patients withIDH2 mutation as detected by an FDA-approved companion diagnostic
Madrid, Spain
08 Sep
- 12 Sep
2017
Zurich, Switzerland
13 Oct
- 14 Oct
2017
Singapore
15 Nov
- 16 Nov
2017
Barcelona, Spain
16 Nov
- 19 Nov
2017
Singapore
17 Nov
- 19 Nov
2017
Singapore
20 Nov
- 21 Nov
2017
